Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review
Ming-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen, Ying-Hsia Shih, Jyun-Hong Chen, Yi-Jou Tai, Ying-Cheng Chiang, Martina Benešová-Schäfer, Hirofumi Hanaoka, Ute Hennrich · 2024
Read Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review by Ming-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen, Ying-Hsia Shih, Jyun-Hong Chen, Yi-Jou Tai, Ying-Cheng Chiang, Martina Benešová-Schäfer, Hirofumi Hanaoka, Ute Hennrich (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11676292.txt.
Description
Ming-Cheng Chang and co-authors review the clinical uses of a radioactive tracer called I-123 MIBG. Their 2024 review covers nuclear medicine scans that light up adrenergic tissue in the body. The tracer has served doctors for decades in both heart and cancer care.
In cardiology, scans with this tracer show how nerves reach the heart muscle, giving outlook clues in heart failure that guide treatment. In oncology, it finds neuroendocrine tumors such as neuroblastoma with high accuracy. Neurologists also use it to separate Parkinson disease from look-alike conditions. The authors note limits, including varied scan protocols and hard readings, and they discuss newer options that may one day compete.
Catalog record
| CREATOR | Ming-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen, Ying-Hsia Shih, Jyun-Hong Chen, Yi-Jou Tai, Ying-Cheng Chiang, Martina Benešová-Schäfer, Hirofumi Hanaoka, Ute Hennrich |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |